Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2020-02-07 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 95% confidence The document is a 'Bokslutsrapport' (Year-end report) for the period January–December 2019, published on February 7, 2020. It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and management commentary (CEO review). As it covers a full fiscal year and provides detailed financial performance data, it qualifies as an Interim/Quarterly Report (IR) in the context of financial reporting standards, as it is the primary financial disclosure document for the period. FY 2019
2020-02-07 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Year-end report' for the period 'January - December 2019'. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed management commentary on business performance, geographic segments, and product areas. It is a substantive financial report for a period shorter than a full fiscal year (in the context of the Q4 breakdown) and the full year, fitting the definition of an Interim/Quarterly Report (IR). FY 2019
2020-02-07 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding ('Sell' transaction) by several holders (Ann-Charlotte Bergström, Eva Forsberg, etc.) in Biotage AB. It explicitly states the 'Reason for major shareholding notification' and provides the 'Before the transaction' and 'After the transaction' share quantities and resulting percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2019-11-11 English
Resolutions at the Extra General Meeting in Biotage AB on November 7, 2019
AGM Information Classification · 99% confidence The document is titled "Resolutions at the Extra General Meeting in Biotage AB on November 7, 2019". It details specific resolutions passed regarding the number of board members, their remuneration, and the election of a new board member and Chairman. This content directly relates to decisions made during a shareholder meeting, specifically an Extra General Meeting (EGM). While the content involves Board/Management changes (MANG) and potentially voting results (DVA), the primary context is the formal record of resolutions passed at the meeting itself. Since the definitions include 'AGM Information' for presentations and materials shared during the Annual General Meeting, and this document details resolutions from an *Extra* General Meeting, the closest fit among the provided codes that captures meeting outcomes is AGM-R, which covers general meeting materials, or DVA for voting results. Given the focus on formal resolutions and elections, AGM-R (AGM Information) is the most appropriate category for documenting the outcomes of a General Meeting, even if it is an EGM, as it pertains to meeting governance and decisions.
2019-11-07 English
Beslut vid extra bolagsstämma i Biotage AB den 7 november 2019
AGM Information Classification · 99% confidence The document is titled "Beslut vid extra bolagsstämma i Biotage AB den 7 november 2019" (Decisions at the Extraordinary General Meeting in Biotage AB on November 7, 2019). It details decisions made regarding the number of board members, director remuneration, and the election of a new board member (Åsa Hedin) and a new chairman (Torben Jørgensen). These decisions relate directly to the governance structure and shareholder voting outcomes of a general meeting. This strongly aligns with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2019-11-07 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding for 'ODIN Forvaltning AS' in 'Biotage AB'. It shows the 'Before the transaction' and 'After the transaction' share counts, the reason ('Buy'), and the resulting percentage of voting rights (5.55148%). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document is a direct notification of a change in significant ownership, not an announcement of a report.
2019-11-06 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.